Valbiotis' Series A Round

Valbiotis raised a round of funding on June 05, 2016.

Valbiotis (EPA: ALVAL), founded in 2014, is a biopharmaceutical company that develops a comprehensive solution to chronic metabolic diseases.…

Articles about Valbiotis' Series A Round: